Clinical Trial

A Study to Evaluate Solriktug in Adult Participants With Asthma

Study acronym: RAINIER
Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Phase 2 study to evaluate the safety, tolerability, PK, immunogenicity, and pharmacodynamics of solriktug with adult participants with asthma.
Protocol Amendment History 2 changes
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-04-22
notable Trial sites reduced: 74 -> 69 locations 2026-04-22
Trial Details
NCT Number NCT06496607
Lead Sponsor Uniquity One (UNI)
Collaborators: DevPro Biopharma
Conditions Asthma
Enrollment 145 participants
Start Date 2024-07-26
Primary Completion 2026-07-06 (estimated)
Study Completion 2026-10-26 (estimated)
Updated on ClinicalTrials.gov 2026-08-11